Related Experiment Video

Updated: Aug 16, 2026

An Alternative Culture Method to Maintain Genomic Hypomethylation of Mouse Embryonic Stem Cells Using MEK Inhibitor PD0325901 and Vitamin C
11:53

An Alternative Culture Method to Maintain Genomic Hypomethylation of Mouse Embryonic Stem Cells Using MEK Inhibitor PD0325901 and Vitamin C

Published on: June 1, 2018

Halogenated thymidine analogues restore the expression of silenced genes without demethylation

Jun Fan1, Ei-ichi Kodama, Yasuhiro Koh

  • 1Laboratory of Virus Immunology, Institute for Virus Research, Kyoto University, Kyoto, Japan.

Cancer Research
|August 3, 2005
PubMed

Insights

Halogenated thymidines can reverse cancer-associated gene silencing without altering DNA methylation. These compounds impact histone modifications, offering a new therapeutic strategy for cancer treatment.

Area of Science:

  • Epigenetics
  • Cancer Biology
  • Drug Discovery

Background:

  • Aberrant DNA methylation causes transcriptional silencing of tumor suppressor genes in cancer.
  • Reversing this epigenetic silencing is a key therapeutic strategy for cancer treatment.

Purpose of the Study:

  • To identify novel inhibitors of transcriptional silencing.
  • To investigate the mechanism of action for identified antisilencing compounds.

Main Methods:

  • Established a retroviral reporter gene screening system to identify silencing inhibitors.
  • Tested over 100 nucleosides for antisilencing activity.
  • Utilized gel mobility shift assays and histone modification analysis.

Main Results:

  • Identified halogenated thymidine analogues (e.g., 5-bromo-2'-deoxyuridine) as potent antisilencing agents.
  • Demonstrated that these compounds reactivate gene transcription without affecting DNA methylation levels.
  • Showed that halogenated thymidines increase histone H3 acetylation and decrease H3 Lys9 methylation, correlating with restored gene expression.

Conclusions:

  • Halogenated thymidines possess antisilencing activity by modulating the interplay between DNA methylation and histone acetylation.
  • These findings suggest a novel therapeutic approach targeting epigenetic dysregulation in cancer.

More Related Videos

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers10:28

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers

Published on: September 20, 2018

Pooled shRNA Screen for Reactivation of MeCP2 on the Inactive X Chromosome11:15

Pooled shRNA Screen for Reactivation of MeCP2 on the Inactive X Chromosome

Published on: March 2, 2018

Related Concept Videos

Chromatin Modification in iPS Cells01:32

Chromatin Modification in iPS Cells

Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Inheritance of Chromatin Structures03:17

Inheritance of Chromatin Structures

Epigenetics is the study of inherited changes in a cell's phenotype without changing the DNA sequences. It provides a form of memory for the differential gene expression pattern to maintain cell lineage, position-effect variegation, dosage compensation, and maintenance of chromatin structures such as telomeres and centromeres. For example, the structure and location of the centromere on chromosomes are epigenetically inherited. Its functionality is not dictated or ensured by the underlying DNA...